GLP-1s and Addictive Behaviors: Emerging Evidence and Practice Insights for Clinicians GLP-1 receptor agonists are best known for their role in diabetes and weight management — but emerging research suggests they may also help reduce substance cravings and addictive behaviors. Our guest presenter is Steven Klein MD,PhD, who has been profiled in The New York Times and Financial…

Introducing DrWell’s Medical Director Collaboration Program The healthcare industry is evolving faster than ever before — and so are the opportunities available to medical professionals. With the rise of nurse practitioners (NPs), physician assistants (PAs), naturopaths and even nurses launching independent practices and service lines, there’s a growing need for experienced physicians to step in…

GLP-1 medications are transforming the way we approach weight management and metabolic health. But as powerful as they are, these therapies can also shift how your body absorbs essential nutrients — and that can affect more than your metabolism. It can also influence your hormones, energy levels, and overall vitality. The Role of Delayed Gastric…